ClinicalTrials.gg
Sign In

Glucose Intolerance clinical trials

The registry lists 793 studies for Glucose Intolerance across more than 10 countries. 115 are recruiting or about to start. 353 of them are mainly about Glucose Intolerance (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

ClinicalTrials.gov finds 1,675 studies for Glucose Intolerance. How that becomes 792 here

This page counts the studies the registry files under Glucose Intolerance, and those it files under no condition that list Glucose Intolerancethemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,675Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −16List Glucose Intolerance as a condition, but the registry did not file them under itMost often written as “Glucose Intolerance During Pregnancy” (11), “Impaired Glucose Tolerance in Obese” (2), and “Prediabetes (Impaired Fasting Glucose and/or Impaired Glucose Tolerance)” (1). The registry filed them under other conditions only, most often Diabetes, Gestational (10) and Prediabetic State (3).
  3. −867Match it another way56 name it in the title, 8 in a keyword, and 803 by a synonym or other text the search reads.
  4. 792The count on this page6 of them list Glucose Intolerance in their own words; the registry filed them under no condition.

Get an email when these change. Save the Glucose Intolerance studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
494
Status unknown
90
Recruiting
70
Active, not recruiting
38
Not yet recruiting
37
Terminated
35

Phase

Phase 2
76
Phase 4
62
Phase 3
39
Phase 1
27
Early Phase 1
6

Where

United States
350
United Kingdom
38
Canada
37
Netherlands
30
China
24
Germany
22

Who runs them

Maastricht University Medical Center (19) · Johns Hopkins University (10) · Yale University (9) · Clinical Nutrition Research Center, Illinois Institute of Technology (9) · Mayo Clinic (8) · Singapore Institute of Food and Biotechnology Innovation (8) · Stanford University (8) · University of California, Los Angeles (8)

What is being tested here

Drugs under test in Glucose Intolerance studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Pioglitazone3212
Metformin2423
Dapagliflozin205
Semaglutide204
Saxagliptin104
Empagliflozin103
Dulaglutide102
Tadalafil112
Ursodeoxycholic Acid102
Avexitide102

Drug classes tested here GLP-1 receptor agonists 4 open · SGLT2 inhibitors 3 open · DPP-4 inhibitors 1 open · PDE5 inhibitors 1 open · Alpha-glucosidase inhibitors 10

Coming up

0phase 3 studies under way
50studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 70 Glucose Intolerance studies recruiting now, 14 (20%) set no upper age limit and 51 (73%) stop at 75 or younger. 10 (14%) take children under 18. 9 (13%) are for women only and 0 (0%) for men only; 33 (47%) take healthy volunteers.

Recruiting studies that take each age, of 70
AgeWomenMen
1010 (14%)9 (13%)
1845 (64%)38 (54%)
3056 (80%)47 (67%)
4058 (83%)49 (70%)
5055 (79%)49 (70%)
6545 (64%)43 (61%)
7528 (40%)27 (39%)
8515 (21%)14 (20%)

Across all 793 studies, recruiting or not: 65% stop at 75 or younger and 39% at 65; 9% take children; 9% are for women only and 5% for men only; 46% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Glucose Intolerance studies take

Of 22 phase 2 interventional studies under Glucose Intolerance, half reached primary completion within 40 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 240 mo14–99 · 22 studies——
Phase 440 mo16–47 · 15 studies——
Interventional, no phase26 mo10–44 · 286 studies9 mo6–37 · 32 studies26 mo11–44 · 254 studies
Observational38 mo30–186 · 33 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting2

Results posted1

Stopped1

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 793. Browse all 793 → or search them.